Influence of dietary gangliosides on neonatal brain development

Nutrition Reviews

Volumn 67, Issue 8, 2009, Pages 451-463

  McJarrow, Paul ^a   Schnell, Nicholas ^a   Jumpsen, Jacqueline ^b   Clandinin, Tom ^b  

^a FONTERRA RESEARCH CENTRE   (New Zealand)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Brain development; Cognitive function; Gangliosides; Infant

Indexed keywords

CERAMIDE; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GANGLIOSIDE GM4; GANGLIOSIDE GT 1B; GANGLIOSIDE GT3; PLACEBO; UNCLASSIFIED DRUG;

ARTIFICIAL MILK; BRAIN DEVELOPMENT; BRAIN FUNCTION; BREAST MILK; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; DIET SUPPLEMENTATION; DIETARY INTAKE; HUMAN; INTESTINE ABSORPTION; INTESTINE CELL; LACTATION; LEARNING; LIPID BLOOD LEVEL; LIPID BRAIN LEVEL; LIPID METABOLISM; LIPOGENESIS; MALNUTRITION; MEMORY; NERVE GROWTH; NERVE SPROUTING; NEUROTRANSMISSION; NOMENCLATURE; NONHUMAN; PERINATAL DEVELOPMENT; RETINA DEVELOPMENT; REVIEW;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL COMMUNICATION; COGNITION; DIET; DIGESTION; FOOD ANALYSIS; GANGLIOSIDES; HUMANS; INFANT, NEWBORN; INTESTINAL ABSORPTION; LACTATION; MILK, HUMAN; NEURONS;

EID: 77956783802     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2009.00211.x     Document Type: Review

References (138)

1. Klenk E. Über die Ganglioside, eine neue Gruppe von zukkerhaltigen Gehirnlipoiden. Z Physiol Chem. 1942;273:76-86.
2. Wiegandt H. Gangliosides. In: Wiegandt H, ed. Glycolipids. Amsterdam: Elsevier; 1985:101-198.
3. Rueda R, Gil A. Role of gangliosides in infant nutrition. In: Huang YS, Sinclair AJ, eds. Lipids in Infant Nutrition. Champaign, IL: AOCS Press; 1998:213-234.
4. LIPIDS MAPS Consortium. Lipid Metabolites and Pathways Strategy. 2008. Available at: http://www.lipidmaps.org/data/classification/LM-classification-w. php?category=4. Accessed 28 April 2008.
5. Fahy E, Subramaniam S, Brown HA, et al. A comprehensive classification system for lipids. J Lipid Res. 2005;46:839-861.
6. Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem. 1963;10:613-623.
7. Moss GP. Nomenclature of Glycolipids. 1997. Available at: http://www.chem.qmul.ac.uk/iupac/misc/glylp.html#7.2. Accessed 10 April 2008.
8. Schauer R. Sialic acids: fascinating sugars in higher animals and man. Zoology. 2004;107:49-64.
9. Bode L, Beermann C, Mank M, Kohn G, Boehm G. Human and bovine milk gangliosides differ in their fatty acid composition. J Nutr. 2004;134:3016-3020.
10. Puente R, Garciapardo LA, Hueso P. Gangliosides in bovinemilk - changes in content and distribution of individual ganglioside levels during lactation. Biol Chem Hoppe- Seyler. 1992;373:283-288.
11. Rueda R, Garcia-Salmeron JL, Maldonado J, Gil A. Changes during lactation in ganglioside distribution in human milk from mothers delivering preterm and term infants. Biol Chem. 1996;377:599-601.
12. Martin-Sosa S, Martin MJ, Castro MD, Cabezas JA, Hueso P. Lactational changes in the fatty acid composition of human milk gangliosides. Lipids. 2004;39:111-116.
13. Ladisch S, Hasegawa A, Li R, Kiso M. Immunosuppressive activity of chemically synthesized gangliosides. Biochemistry. 1995;34:1197-1202.
14. Rosenberg A, Stern N. Changes in sphingosine and fatty acid components of the gangliosides in developing rat and human brain. J Lipid Res. 1966;7:122-131.
15. Vesper H, Schmelz EM, Nikolova-Karakashion MN, Dillehay DL, Lynch DV, Merrill AH Jr. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr. 1999;129:1239-1250.
16. Li S-C, Chien J-L, Wan CC, Li T-T. Occurrence of glycosphingolipids in chicken egg yolk. Biochem J. 1978;173:697-699.
17. Shiraishi T, Uda Y. Characterization of neutral sphingolipids and gangliosides from chicken liver. J Biochem (Tokyo). 1986;100:553-561.
18. Ohashi M. A comparison of the ganglioside distribution of fat tissues in various animals by two-dimensional thin layer chromatography. Lipids. 1979;14:52-57.
19. Moore KH, Ettinger AC, Yokoyama MT. Variation in ganglioside content of bovine dairy products. J Food Comp Anal. 2000;13:783-790.
20. Rueda R, Maldonaldo J, Narbona E, Gil A. Neonatal dietary gangliosides. Early Hum Dev. 1998;53(Suppl):S135-S147.
21. Pan XL, Izumi T. Variation of the ganglioside compositions of human milk, cow's milk and infant formulas. Early Hum Dev. 2000;57:25-31.
22. Pan XL, Izumi T. Chronological changes in the ganglioside composition of human milk during lactation. Early Hum Dev. 1999;55:1-8.
23. Martin MJ, Martin-Sosa S, Garcia-Pardo LA, Hueso P. Distribution of bovine milk sialoglycoconjugates during lactation. J Dairy Sci. 2001;84:995-1000. (Pubitemid 33609686)
24. Martin MJ, Martin-Sosa S, Hueso P. Bovine milk gangliosides: changes in ceramide moiety with stage of lactation. Lipids. 2001;36:291-298.
25. McJarrow P, Patel S, Coolbear F, MacGibbon A. Measurements of bovine milk powder ganglioside GD3: analysis of seasonal trends and international comparisons. Trends Glycosci Glycotech. 2006;18(Suppl):S41.
26. Laegreid A, Otnaess ABK, Fuglesang J. Human and bovinemilk - comparison of ganglioside composition and enterotoxin-inhibitory activity. Pediatr Res. 1986;20:416-421.
27. Takamizawa K, Iwamori M, Mutai M, Nagai Y. Selective changes in gangliosides of human-milk during lactation - a molecular indicator for the period of lactation. Biochim Biophys Acta. 1986;879:73-77.
28. Park EJ, Suh M, Clandinin MT. Dietary ganglioside and long-chain polyunsaturated fatty acids increase ganglioside GD3 content and alter the phospholipid profile in neonatal rat retina. Invest Ophthalmol Vis Sci. 2005; 46:2571-2575.
29. Park EJ, Suh M, Ramanujam K, Steiner K, Begg D, Clandinin MT. Diet-induced changes in membrane gangliosides in rat intestinal mucosa, plasma and brain. J Pediatr Gastroenterol Nutr. 2005;40:487-495.
30. Colarow L, Turini M, Teneberg S, Berger A. Characterization and biological activity of gangliosides in buffalo milk. Biochim Biophys Acta. 2003;1631:94-106.
31. Masco D, Flott B, Seifert W. Astrocytes in cell culture incorporate GM1 ganglioside. Glia. 1989;2:231-240.
32. Fishman PH, Pacuszka T, Hom B, Moss J. Modification of ganglioside GM1: effect of lipid moiety on choleragen action. J Biol Chem. 1980;255:7657-7664.
33. Whitmore CD, Hindsgaul O, Palcic MM, Schnaar RL, Dovichi NJ. Metabolic cytometry. Glycosphingolipid metabolism in single cells. Anal Chem. 2007;79:5139-5142.
34. Leskawa KC, Hogan EL. Regulation of glycolipid synthesis during differentiation of clonal murine muscle cells. Mol Cell Biochem. 1990;96:163-173.
35. Keenan TW. Composition and synthesis of gangliosides in mammary gland and milk of the bovine. Biochim Biophys Acta. 1974;337:255-270.
36. Fishman PH, Moss J, Manganiello VC. Synthesis and uptake of gangliosides by cholergen-responsive human fibroblasts. Biochemistry. 1977;16:1871-1875.
37. Giglioni A, Chigorno V, Pitto M, Valsecchi M, Palestini P, Ghidoni R. Effect of the different supramolecular organization on the uptake and metabolization of exogenous GM1 ganglioside by human fibroblasts. Chem Phys Lipids. 1990;55:207-213.
38. Ackerman GQ, Wolken KW, Gelder FB. Surface distribution of monosialoganglioside GM1 on human blood cells and the effect of exogenous GM1 on human blood cells and the effect of exogenous GM1 on neuraminidase on cholera toxin surface lebeling. J Histochem Cytochem. 1980;28: 1100-1112.
39. Krishnaraj R, Saet YA, Kemp RG. Binding of monosialoganglioside by murine thymus cells in vitro. Cancer Res. 1980;40:2808-2813.
40. Saqr HE, Pearl DK, Yates AJ. A review and predictive models of ganglioside uptake by biological membranes. J Neurochem. 1993;61:395-411.
41. Schnabl K, Larcelet M, ClandininMT, Thomson ABR. Absorption of exogenous ganglioside GD3 by human intestine CaCo-2 cells. FASEB J. 2007;21:A699.
42. Mobius W, Herzog V, Sandhoff K, Schwarzmann G. Gangliosides are transported fromthe plasmamembrane to intralysosomal membranes as revealed by immuno-electron microscopy. Biosci Rep. 1999;19:307-316.
43. Ghidoni R, Sonnino S, Chigorno V, Venerando B, Tettamanti G. Occurrence of glycosylation and deglycosylation of exogenously administered ganglioside GM1 in mouse liver. Biochem J. 1983;213:321-329.
44. Ogura K, Handa S. Metabolism of exogenous gangliosides GM1 and chemically modified GM1 in mice. J Biochem (Tokyo). 1988;104:87-92.
45. Hungund BL, Morishima HO, Gokhale VS, Cooper TB. Placental-transfer of (H-3)-GM1and its distribution tomaternal and fetal tissues of the rat. Life Sci. 1993;53:113-119.
46. Mitchell MD, Henare K, Lowe E, Naylor M, Fong B, McJarrow P. Transfer of gangliosides across the human placenta. Early Hum Dev. 2007;81(Suppl):S149.
47. Fong B, Norris C, Lowe E, Vickers M, McJarrow P. Dietary supplementation of rats during pregnancy with dairy derived lipid product significantly increases brain gangliosides in two day old pups. Paper presented at: 8th International Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) May18-May 22, 2008; Kansas City.
48. Idota T, Kawakami H. Inhibitory effects of milk gangliosides on the adhesion of Escherichia coli to human carcinoma cells. Biosci Biotech Biochem. 1995;59:69-72.
49. Schmidt DG, Meijer RJGM, Slangen CJ, Van Beresteijn ECH. Raising the pH of the pepsin-catalysed hydrolysis of bovine whey proteins increases the antigenicity of the hydrolysates. Clin Exp Allergy. 1995;25:1007-1017.
50. Nakano T, Sugawara M, Kawakami H. Sialic acid in human milk: composition and functions. Acta Paediatr Taiwan. 2000;42:11-17.
51. Bouhours D, Bouhours JF. Developmental changes of hematoside of rat small intestine. Postnatal hydroxylation of fatty acids and sialic acid. J Biol Chem. 1983;258:299-304.
52. Holgersson J, Stromberg N, Breimer ME. Glycolipids of human large intestine: difference in glycolipid expression related to anatomical localization, epithelial/no-epithelial tissue and the ABO, Le and Se phenotypes of donors. Biochimie. 1988;70:1565-1574.
53. Stevenson BR. Understanding tight junction clinical physiology at the molecular level. J Clin Invest. 1999;104:3-4.
54. Park EJ, Thomson ABR, Clandinin MT. Dietary ganglioside protects the degradation of occludin tight junction protein in acute intestinal inflammation by decreasing nitric oxide and increasing interleukin 10 production in the rat. J Pediatr Gastroenterol Nutr. 2007;44:119.
55. Trinchera M, Ghidoni R. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver. J Biochem (Tokyo). 1990; 107:619-623.
56. Chen HY, Challa AK, Varki A. 9-O-acetylation of exogenously added ganglioside GD3 - The GD3 molecule induces its own O-acetylation machinery. J Biol Chem. 2006;281:7825-7833.
57. Ghidoni R, Trinchera M, Venerando B, Fiorilli A, Sonnino S, Tettamanti G. Incorporation and metabolism of exogenous GM1 ganglioside in rat-liver. Biochem J. 1986;237:147-155.
58. Park EJ, Suh M, Thomson B, Thomson ABR, Ramanujam K, Clandinin MT. Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. Glycobiology. 2005;15:935-942.
59. Larson G, Falk P, Hynsjo L, Midtved AC, Midtvedt T. Faecal excretion of glycosphingolipids of breast-fed and formulafed infants. Microb Ecol Health Dis. 1990;3:305-319.
60. McJarrow P, Garman J, Harvey S, van Amelsfort A. A dairy process and product. PCT patent application WO/2003/ 049547. New Zealand Dairy Board. 2003.
61. Senn HJ, Orth M, Fitske E,Wieland H, GerokW. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur J Biochem. 1989;181:657-662.
62. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31-39.
63. Simons M, Friedrichson T, Schulz JB, Pitto M, Masserini M, Kurzchalia TV. Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol Biol Cell. 1999;10:3187-3196.
64. Bremer EG, Schlessinger H, Hakamori S. Gangliosidemediatedmodulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem. 1986;261:2434-2440.
65. Tagami S, Inokuchi Ji J, Kabayama K, et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem. 2002;277:3085-3092.
66. Wang B, Brand-Miller J. The role and potential of sialic acid in human nutrition. Eur J Clin Nutr. 2003;57:1351-1369.
67. Kracun I, Rosner H, Drnovsek V, et al. Gangliosides in the human brain-development and aging. Neurochem Int. 1992;20:421-431.
68. Rouser G, Yamamoto A, Kritchevsky G. Cellular membranes. Structure and regulation of lipid class composition, species differences, changes with age, and variations in some pathological states. Arch Int Med. 1971;127:1105-1121.
69. Svennerholm L, Ställberg-Stenhagen S. Changes in the fatty acid composition of cerebrosides and sulfatides of human nervous tissue with age. J Lipid Res. 1968;9:215-225.
70. Bourre JM, Bonneil M, Clement M, et al. Function of dietary polyunsaturated fatty acids in the nervous system. Prost Leuko Essent Fatty Acids. 1993;48:5-15.
71. Dyer JR, Greenwood CE. Neural 22-carbon fatty acids in the weanling rat respond rapidly and specifically to a range of dietary linoleic to alpha-linolenic fatty acid ratios. J Neurochem. 1991;56:1921-1931.
72. Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta. 1984;79:89-137.
73. Foot M, Cruz TF, ClandininMT. Influence of dietary fat on the lipid composition of rat brain synaptosomal and microsomal membranes. Biochem J. 1982;208:631-641.
74. Foot M, Cruz TF, Clandinin MT. Effect of dietary lipid of symaptosomal acetyl-cholinesterase activity. Biochem J. 1983;211:507-509.
75. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev. 1980;4:131-138. (Pubitemid 10064581)
76. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev. 1980;4:121-129. (Pubitemid 10064580)
77. Schengrund CL, RepmanMA. Cell culture of sixteen-day-old rat embryo cerebra and associated changes in ganglioside pattern. J Neurochem. 1977;29:923-927.
78. Yavin E, Yavin Z. Ganglioside profiles during neural tissue development; acquisition in the prenatal rat brain and cerebral cell cultures. Dev Neurosci. 1979;2:25-37.
79. Dreyfus H, Louis JC, Harth S, Mandel P. Gangliosides in cultured neurons. Neuroscience. 1980;5:1647-1655.
80. Ogiso M, Ohta M, Harada Y, Kubo H, Hirano S. Developmental change in ganglioside expression in primary culture of rat neurons. Neuroscience. 1991;41:167-176.
81. Letinic K, Heffer-Lauc M, Rösner H, Kostovic I. C-pathway polysialogangliosides are transiently expressed in the human cerebrum during fetal development. Neuroscience. 1998;86:1-5.
82. Martinez M, Ballabriga A, Gil-Gibernau JJ. Lipids of the developing human retina: 1. Total fatty acids, plasmalogens, and fatty acid composition of ehtanolamine and choline phosphoglycerides. J Neurosci Res. 1988;20:484-490.
83. Daniotti JL, Landa CA, Rösner H, Maccioni HJ. GD3 prevalence in adult rat retina correlates with the maintenance of a high GD3-/GM-2 synthase activity ratio throughout development. J Neurochem. 1991;57:2054-2058.
84. Fontaine V, Hicks D, Dreyfus H. Changes in ganglioside composition of photoreceptors during postnatal maturation of the rat retina. Glycobiology. 1998;8:183-190. (Pubitemid 28098219)
85. Chavko M, Nemoto EM, Melick JA. Regional lipid composition in the rat brain. Mol Chem Neuropathol. 1993;18:123-131.
86. Svennerholm L, Bostrom K, Jungbjer B, Olsson L. Membrane-lipids of adult human brain - lipid-composition of frontal and temporal-lobe in subjects of age 20 to 100 years. J Neurochem. 1994;63:1802-1811.
87. Kracun I, Rosner H, Cosovic C, Stavljenic A. Topographical atlas of the gangliosides in the adult human brain. J Neurochem. 1984;43:979-989.
88. Wiegandt H. The subcelleular localization of gangliosides in the brain. J Neurochem. 1967;14:671-674.
89. Vanier MT, Holm M, Månsson JE, Svennerholm L. The distribution of lipids in the human nervous system - V. Gangliosides and allied neutral glycolipids of infant brain. J Neurochem. 1973;21:1375-1384.
90. Ledeen RW, Skrivanek JA, Tirri J, Margolis RK, Margolis RU. Gangliosides of the neuron: localization and origin. Adv Exp Med Biol. 1976;71:83-103.
91. Ledeen RW,Wu GS, Lu ZH, Kozireski-Chuback D, Fang Y. The role of GM1 and other gangliosides in neuronal differentiation - overview and new findings. Ann NY Acad Sci. 1998;845:161-175.
92. Roisen FJ, Bartfeld H, Nagele R, Yorke G. Ganglioside stimulation of axonal sprouting in vitro. Science. 1981;214:577-578.
93. Palestini P, Masserini M, Fiorilli A, Calappi E, Tettamanti G. Age related changes in the ceramide composition of the major gangliosides present in rat brain sub-cellular fractions enriched in plasma membranes of neuronal and myelin origin. J Neurochem. 1993;61:955-960.
94. Rösner H. Gangliosides and brain development. In: Nicolini M, Zatta PF, eds. Glycobiology and the Brain. Oxford, UK: Pergamon; 1994:19-36.
95. Rösner H. Developmental expression and possible roles of gangliosides in brain development. Prog Mol Subcell Biol. 2003;32:49-73.
96. Mendez-Otero R, Santiago MF. Functional role of a specific ganglioside in neuronal migration and neurite outgrowth. Braz J Med Biol Res. 2003;36:1003-1013.
97. Yamashita T, Wu YP, Sandhoff R, et al. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci. 2005;102:2725-2730.
98. Hakamori SI. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interaction. J Biol Chem. 1990;265:18713-18716.
99. Ledeen RW. Biosynthesis, metabolism, and biological effects of gangliosides. In: Margolis RU, Margolis RK, eds. Neurobiology of Glycoconjugates. NewYork: Plenum Publishing Corporation; 1989:42-83.
100. VanierMT, Holm M, Ohman R, Svennerholm L. Development profiles of gangliosides in human and rat brain. J Neurochem. 1971;18:581-592.
101. Svennerholm L, Rynmark BM, Vilbergsson G, et al. Gangliosides in human fetal brain. J Neurochem. 1991;56:1763-1768.
102. Stojiljkovic M, Blagojevic T, Vukosavic S, et al. Ganglioside GM1 and GM3 in early human brain development: an immunocytochemical study. Int J Dev Neurosci. 1996;14:35-44.
103. Segler-Stahl K, Webster JC, Brunngraber EG. Changes in the concentration and composition of human brain gangliosides with aging. Gerontology. 1983;29:161-168.
104. Yamashita T, Hashiramoto A, Haluzik M, et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA. 2003;100:3445-3449.
105. Proia RL. Gangliosides help stabilize the brain. Nat Genet. 2004;36:1147-1148.
106. Sheikh KA, Sun J, Liu YJ, et al.Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA. 1999;96:7532-7537.
107. Nakatsuji Y, Miller RH. Selective cell-cycle arrest and induction of apoptosis in proliferating neural cells by ganglioside GM3. Exp Neurol. 2001;168:290-299.
108. Ledeen RW,Wu GS. Ganglioside function in calcium homeostasis and signaling. Neurochem Res. 2002;27:637-647.
109. Svennerholm L. Gangliosides and synaptic transmission. Adv Exp Med Biol. 1980;125:533-544.
110. Wu GS, Vaswani KK, Lu ZH, Ledeen RW. Gangliosides stimulate calcium flux in neuro 2A cells and require exogenous calcium for neuritogenesis. J Neurochem. 1990;55:484-491.
111. Spoerri PE, Dozier AK, Roisen FJ. Calcium regulation of neuronal differentiation: the role of calcium in GM1-mediated neuritogenesis. J Neurochem. 1990;56:177-188.
112. Sachinidis A, Kraus R, Seul C, et al. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by differentmechanisms. Eur J Cell Biol. 1996;71:79-88.
113. Gouy H, Deterre P, Debre P, Bismuth G. Cell calcium signaling via GM1 cell surface gangliosides in the human Jurkat T cell line. J Immunol. 1994;152:3271-3281.
114. Vasylevskaya VV, Bochkov VN, Prokazova NV, Tkachuk VA. Characteristics and regulation of ganglioside-induced elevation of free cytoplasmic Ca2+ in human blood platelets. Biochim Biophys Acta. 1992;1127:221-225.
115. Agopyan N, Miu P, Krnjevic K. Modulation of high-threshold Ca current and spontaneous postsynaptic transient currents by phorbal 12,13-diacetate, 1-(5-isoquinolinesulfonyl)-2- methyl piperazini (H-7), and monosialoganglioside (GM1) in CA1 pyramidal neurons of rat hippocampus in vitro. Hippocampus. 1993;3:67-76.
116. Xie X, Wu G, Lu ZH, Ledeen RW. Potentiation of a sodiumcalcium exchanger in the nuclear envelope by nuclear GM1 ganglioside. J Neurochem. 2002;81:1185-1195.
117. Leon A, Facci L, Toffano G, Sonnino S, Tettamanti G. Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside. J Neurochem. 1981;37:350-357.
118. Tanaka Y, Waki H, Kon K, Ando S. Gangliosides enhance KCl-induced Ca2+ influx and acetylcholine release in brain synaptosomes. Neuroreport. 1997;8:2203-2207.
119. Rahmann H. Brain gangliosides and memory formation. Behav Brain Res. 1995;66:105-116.
120. Morgan BL, Winick M. Effects of environmental stimulation on brain N-acetylneuraminic acid content and behavior. J Nutr. 1980;110:425-432. (Pubitemid 10075544)
121. Reddy PV, Sastry PS. Effect of undernutrition on the metabolism of phospholipids and gangliosides in developing rat brain. Br J Nutr. 1978;40:403-411.
122. Morgan BL, Winick M. Effects of administration of N-acetylneuraminic acid (NANA) on brain NANA content and behavior. J Nutr. 1980;110:416-424. (Pubitemid 10075543)
123. Popov N. Effects of D-galactosamine and D-glucosamine on retention performance of a brightness discrimination task in rats. Biochim Biophys Acta. 1985;44:611-622.
124. Haselhorst U, Krusche A, Schenk H, Hantke H. The influence of gangliosides on active conditioning avoidance response on the two-way shuttle box. Biomed Biochim Acta. 1988;47:475-480.
125. Mei ZT, Zheng J-Z. Effects of exogenous gangliosides on learning and memory in rats. Jpn J Physiol. 1993;43(Suppl 1):S295-S299.
126. Silva RH, Bellot RG, Vital MABF, Frussa-Filho R. Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice. Psychopharmacology. 1997;129:322-328.
127. Haselhorst U, Krusche A, Schenk H, Hantke H, Grecksch G. Effect of gangliosides on memory formation of a conditioned avoidance response (CAR). Biomed Biochim Acta. 1990;49:523-526.
128. Wainwright PE, Lomanowska AM, McCutcheon D, Park EJ, ClandininMT, Ramanujam KS. Postnatal dietary supplementation with either gangliosides or choline: effects on spatial short-term memory in artificially reared rats. Nutr Neurosci. 2007;10:67-77.
129. Abraham RR, Abraham RM,Wynn V. A double blind placebo controlled trial of mixed gangliosides in diabetic peripheral and autonomic neuropathy. Adv Exp MedBiol. 1984; 174:607-624.
130. Bradley WG. Double-blind controlled trial of purified brain gangliosides in amyotrophic lateral sclerosis and experience with peripheral neuropathies. Adv Exp Med Biol. 1984; 174:565-573.
131. Abraham RR, Levy DM, Abraham RM. Changes in thermal sensation in diabetic patients after treatment with gangliosides. Diabetes Res. 1988;7:129-135.
132. Spuler M, Dimpfel W, Tullner H-U. Ganglioside therapy in experimental diabetic neuropathy. Arzneimittel-Forsch/Drug Res. 1988;38:881-884.
133. Bradley WG. Critical review of gangliosides and thyrotropinreleasing hormone in peripheral neuromuscular diseases. Muscle Nerve. 1990;13:833-842.
134. Sobolewski P. Cronassial in the treatment of neuropathies and atrophy of the optic nerve. Klin Oczna. 1992;94:57-58.
135. Vickers MH, Guan J, Gustavsson M, et al. Effects of oral supplementation with a complex milk lipid containing gangliosides during the neonatal and early postnatal period on cognition and learning in young normal rats. Paper presented at: 8th International Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) May18-May 22, 2008; Kansas City.
136. Watson MB, Clandinin MT. Dietary ganglioside and neurochemistry in the developing rat. Glycobiology. 2006; 16:1148-1149.
137. Wang B, McVeagh P, Petocz P, Brand-Miller J. Brain ganglioside and glycoprotein sialic acid in breastfed compared with formula-fed infants. Am J Clin Nutr. 2003;78:1024-1029.
138. Xu X-Z, Zhu T-C. Effect of ganglioside in repairing the neurological function of children with cerebral palsy: analysis of the curative efficacy in 2230 cases. Chin J Clin Rehab. 2005;9:122-123 (in Chinese).